Filling Gaps in Drug Discovery Pipelines: From Compound Candidate to Clinical Reality
white paper
internal
In this white paper, our Curia experts discuss the existing partnerships with NIH that allow the chance to bring together government, academic, and industry resources through strategic initiatives that streamline processes and maximize benefits.
Download this white paper to discover:
- What are the different programs you can apply to if you are looking for government funding
- The advantages of pairing deep expertise with unparalleled technology access, including a recent success story
- The benefits of strategic government partnerships beyond the duration of an NIH program. For example, streamlining drug development by continuing to work with contract partners like Curia for manufacturing, and formulation services